2021 - NCI Bottom Line: A Blog about Grants and More
-
On the heels of Congress extending the Continuing Resolution for FY 2022, the NCI Director addresses what short-term funding means for NCI’s grantee community. As in years past, Dr. Sharpless highlights the Institute’s interim payline policies for both competing and noncompeting grants.
-
With special authorities granted in the National Cancer Act of 1971, NCI has been submitting an annual budget proposal directly to the President and Congress for 50 years. In early September, NCI released the Annual Plan & Budget Proposal for Fiscal Year 2023. In this edition of the NCI Bottom Line blog, Dr. Michelle Bennett discusses priorities from the annual plan that are especially relevant to current and future NCI-funded researchers, including NCI’s commitment to investigator-initiated research and raising the R01 payline to fund more highly meritorious research.
-
In this edition of the NCI Bottom Line, the Center for Cancer Training Director Dr. Oliver Bogler details numerous changes to the institute’s training programs and how NCI intends to stay abreast of the needs of future generations of cancer researchers. Specifically, Dr. Bogler discusses changes to the K08 career development program, inclusivity within the T32 grant program, and details of a new developmental program for early-stage surgeon-scientists.
-
NCI’s Center for Research Strategy analyzed 26 years of data to better understand the funding trends of the NCI R01-funded workforce, focusing on the age and career stage of investigators. This data, recently published by Dr. L. Michelle Bennett et al. in the Journal of Clinical Investigation, shows how NCI is actively developing policies based on this understanding and looking into methods that sustainably fund more principal investigators.
-
With a final fiscal year 2021 budget passed by Congress, NCI Director, Dr. Norman E. Sharpless, turns to the NCI Bottom Line blog to provide the grantee community with an update on how the NCI plans to use the budget increase to expand paylines. With this continued increase in funding from Congress, NCI remains on its current trajectory to achieve the goal of reaching the 15th percentile by FY 2025.
-
As we near the April deadline to submit Expressions of Interest, Dr. Singer takes the opportunity to provide an update to the cancer research community on the Cancer Grand Challenges program and nine scientific challenges. Cancer Grand Challenges will fund novel ideas by multidisciplinary research teams from around the world that offer the potential to advance bold cancer research and improve outcomes for people affected by cancer. Additionally, Dr. Singer expands on the joint January 12th preapplication webinar which served to answer the research community’s questions about the program and application processes.